Clinical Trial Update: Iron-Chelating Therapy and Friedreich Ataxia [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 1/Phase 2 clinical trial evaluating an iron-chelating therapy for Friedreich Ataxia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Iron-chelating therapy

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Friedreich Ataxia | Phase 1, Phase 2 | Status: COMPLETED